Whim Syndrome
📧 Sign up to get email alerts when something new happens for Whim Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Phase I Study of Mozobil in the Treatment of Patients With WHIMS [Phase 1, Phase 2]
A Phase I/II clinical trial is evaluating Mozobil (plerixafor) for the treatment of WHIM syndrome, and the study is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-07-29Clinical Trial Update: Efficacy and Safety Study of Mavorixafor in Participants With Warts, Hypogammaglobulinemia, Infections, and Myelokathexis (WHIM) Syndrome [Phase 3]
Phase 3 trial evaluating the efficacy and safety of mavorixafor in WHIM syndrome. The study is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2024-10-30Clinical Trial Update: A Dose Determination and Safety Study of X4P-001 (Mavorixafor) in Participants With Warts, Hypogammaglobulinemia, Infections, and Myelokathexis (WHIM) Syndrome [Phase 2]
A Phase 2 dose-determination and safety study of X4P-001 (mavorixafor) in WHIM syndrome has completed, with results posted in 2024 describin…
-
FDA approval · 2024-04-26FDA Approved: XOLREMDI — Original Application (X4 Pharmaceuticals, Inc.)
FDA approves Xolremdi (mavorixafor) via original NDA from X4 Pharmaceuticals for the treatment of WHIM syndrome, marking the first approved …
-
CLINICAL_TRIALS trial_result · 2012-06-15Clinical Trial Update: AMD 3100 for Treatment of Myelokathexis [Phase 1]
A Phase 1 trial of AMD 3100 (plerixafor) for neutropenia in WHIM syndrome (myelokathexis); results were posted in 2012.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.